TAK-861, TAK-861 placebo (same excipients as TAK-861)
TAK-861-3002
Phase 3 small_molecule active
Quick answer
TAK-861, TAK-861 placebo (same excipients as TAK-861) for Narcolepsy with Cataplexy (Narcolepsy Type 1) is a Phase 3 program (small_molecule) at Takeda with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda
- Indication
- Narcolepsy with Cataplexy (Narcolepsy Type 1)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active